<DOC>
	<DOCNO>NCT01073943</DOCNO>
	<brief_summary>Subjects undergoing elective complete colonoscopy randomly receive either PicoPrep : 2-sachets oral solution two divided dos give afternoon ( first dose - sachet ) 6 hour later even ( second dose - sachet ) , give day procedure HalfLytely : oral solution two 5 mg Bisacodyl tablet , give day procedure evaluate effectiveness , tolerability safety .</brief_summary>
	<brief_title>Investigation PicoPrep Versus HalfLytely Bowel Preparation Colonoscopy - Day Before PicoPrep</brief_title>
	<detailed_description />
	<mesh_term>Bisacodyl</mesh_term>
	<mesh_term>Picosulfate sodium</mesh_term>
	<criteria>Male female , age 18 80 year , inclusive , schedule undergo elective colonoscopy Female patient post menopausal ( woman â‰¥ 45yrs menstrual period least 12 month without alternative medical cause ) , surgically sterile , use medically approve contraception , throughout trial period Females childbearing potential must undergo pregnancy test screen randomization Subjects must equal 3 spontaneous bowel movement per week one month prior colonoscopy Subjects willing , able competent complete entire procedure comply study instruction Written inform consent obtain prior study Acute surgical abdominal condition ( e.g . acute obstruction perforation , etc . ) Active ( acute/exacerbation of/severe/uncontrolled ) Inflammatory Bowel Disease ( IBD ) Any prior colorectal surgery , exclude appendectomy , hemorrhoid surgery prior endoscopic procedure Colon disease ( history colonic cancer , toxic megacolon , toxic colitis , idiopathic pseudoobstruction , hypomotility syndrome ) Ascites Gastrointestinal disorder ( active ulcer , outlet obstruction , retention , gastroparesis , ileus ) Upper gastrointestinal surgery ( gastric resection , gastric banding , gastric bypass ) Uncontrolled angina and/or Myocardial Infarction ( MI ) within last 3 month , Congestive Heart Failure ( CHF ) , uncontrolled hypertension Renal insufficiency ( serum creatinine potassium must within normal limit ) Participation investigational study within 30 day prior receive study medication ( within 60 day investigational drug elimination halflife great 15 day ) Any clinically significant laboratory value screening , include preexist electrolyte abnormality , base clinical history Investigator feel may affect study evaluation Hypersensitivity active ingredient</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>October 2012</verification_date>
	<keyword>Bowel Preparation</keyword>
	<keyword>Colonoscopy</keyword>
</DOC>